In a world first, a 25-year-old woman in China has had her type 1 diabetes reversed through a groundbreaking stem cell therapy.
"A 25-year-old woman in China is the first person worldwide to have type 1 diabetes reversed through stem cell therapy.
The therapy used the patient’s own cells to create personalized stem cells, which were then used to grow fresh insulin-producing islets.
This breakthrough offers hope for millions with diabetes, potentially eliminating the need for daily insulin injections and reducing complications.
In a groundbreaking medical achievement, a 25-year-old woman in Tianjin, China, has had her type 1 diabetes reversed through a novel stem cell therapy. This marks the first time such a feat has been accomplished globally, offering new hope for millions living with the chronic condition.
The patient, who had been struggling with type 1 diabetes, underwent a pioneering treatment that involved converting her own cells into personalized stem cells. These stem cells were then used to grow fresh clusters of ‘islets,’ the hormone-producing cells in the pancreas responsible for regulating blood sugar levels.
As Nature reports, this therapy’s unique approach of transplanting the newly created islets into the patient’s upper abdomen near her pancreas sets it apart from previous islet transplant methods. This strategic placement allows for easier monitoring via MRI, a significant advantage over traditional liver transplants.
“I can eat sugar now,” the woman said on a call with Nature. After over a year since the transplant, she says, “I enjoy eating everything — especially hotpot.” The woman asked to remain anonymous for privacy reasons.
Experts are astonished at the results, according to Timesnownews. “They’ve completely reversed diabetes in the patient, who was requiring substantial amounts of insulin beforehand,” said Dr. James Shapiro, a transplant surgeon and researcher at the University of Alberta in Edmonton, Canada.
The implications of this breakthrough are far-reaching, as it could potentially revolutionize the way we treat diabetes. By using a patient’s own cells to create personalized stem cells, this therapy bypasses the limitations of donor islet shortages and the need for immunosuppressive drugs, which have hindered the success of conventional transplant methods.
‘If this is applicable to other patients, it’s going to be wonderful,’ diabetes researcher Daisuke Yabe of Japan’s Kyoto University told reporters via Daily Mail.
As the world watches closely, the success of this case sparks hope for the millions of individuals living with type 1 diabetes. It represents a significant step forward in regenerative medicine and paves the way for further research and development in the field."
Black women!
As Artemis II captured the world’s attention, it also put a wider spotlight on the Black women helping shape this moment across science, leadership, astronaut training, and storytelling.
This is bigger than one viral moment but a reminder that Black women are not just watching history happen. They are helping make it possible.
Tag a Black woman making it happen!
-
👉🏾 Follow @becauseofthem and be part of a community built on positive, uplifting Black history, stories, news, and culture ✨
Feeling abandoned and overwhelmed, families are turning to controversial new therapies backed by the US health secretary
Ed Pilkington at The Guardian:
Landyn Holdren is an eight-year-old autistic child who has high support needs and is nonspeaking. His mother, Christy Holdren, says he can be self-harming, slapping his chest, face or head when distressed.
Later this month, she will spend $15,000 on an unapproved stem cell treatment she hopes might help him.
They went for the first round of the treatment last October at a Florida stem cell clinic that charged Holdren $12,500. The procedure is not approved by the Food and Drug Administration (FDA), and scientists say there is little evidence it works for autism, raising concerns that desperate families are being sold false hope.
Yet as stem cell clinics multiply across America, they are finding an influential ally in the US health secretary, Robert F Kennedy Jr.
Holdren knows there is no “cure” for autism, which is a condition, not a disease. But she said she was determined to do her utmost to help her child.
“He actually looks at us and not through us, and that’s huge for us,” she said of the small but significant changes she believes followed Landyn’s first infusion. “We can cut his hair without him freaking out. That may sound little, but when you have to wrangle an alligator to clip his nails, that’s big things.”
Seven months on, Landyn’s aggressive and self-harming behaviour is worsening again. So, despite the cost that has driven Holdren to take out a loan against her retirement savings, she is preparing to return for a second stem cell dose.
A ‘completely bogus’ treatment
The Holdrens are far from alone.
Across the US, children with autism as young as 18 months old are being given unapproved stem cell treatments at clinics in Florida, Texas and elsewhere, part of a growing market operating beyond the bounds of FDA approval.
The procedure often involves the child being sedated before receiving intravenous doses of millions of stem cells commonly derived from human umbilical cords harvested at birth.
In some cases, the doctors selling the treatments have no scientific expertise in autism or child development. Instead, physicians from unrelated specialties, including plastic surgery and orthopaedics, have entered the booming stem cell sector, billing the procedures as “regenerative medicine” for children, some of whom have severe disabilities.
Up to now, Americans seeking therapies that lack federal approval have tended to look abroad. That has fed the flourishing multibillion-dollar industry of “stem cell tourism” in places such as Mexico and Panama – and as far afield as Abu Dhabi.
Now the practice appears to be gaining strength inside the US, and there are fears that under Kennedy’s leadership, the FDA may be loosening its rigorous regulation.
Paul Knoepfler, a stem cell biologist at the UC Davis School of Medicine who acts as an unofficial watchdog of stem cell clinics through his blog, the Niche, has detected a slump in enforcement activity under Kennedy. He is concerned that the pattern will harden into a change of government policy.
“We haven’t seen the FDA taking action in the last 18 months. I think we’re going to see big change coming from the FDA very soon, backing off oversight of birth-related stem cells,” he said.
Arnold Kriegstein, professor of neurology at the University of California San Francisco who led its stem cell research for almost two decades until 2022, said that concern was growing about the spread of expensive and medically unproven interventions on highly vulnerable children.
“I’m appalled that this is being allowed to go on in the US, and that so many desperate people are being taken advantage of with a ‘treatment’ that in my view is completely bogus.”
The FDA has so far only approved stem cells for use in a very narrow range of cases, such as bone marrow transplants or to boost a cancer patient’s immune system after chemotherapy using their own, their siblings’ or unrelated donors’ matching stem cells. But the technique is attracting mounting attention for use in a range of treatments.
Stem cells are the body’s master cells, from which all other cells derive. They can renew themselves, develop into specialised cells and heal after injury.
[...]
The Tijuana experiment
For years, advocates of fringe autism treatments largely operated on the margins of US medicine. Under Kennedy, some are now gaining unprecedented influence with the federal government.
In January, Kennedy appointed Tracy Slepcevic, the mother of an autistic child and a vocal supporter of alternative therapies, to a federal committee that helps steer national autism research policy. She was one of 21 new appointees who were elevated to the panel after Kennedy dismissed all its previous members. Several of the new advisers, Slepcevic included, share the health secretary’s skepticism toward vaccines.
Slepcevic describes in her book, Warrior Mom, how she arranged for her child to undergo several unproven treatments including high-dose vitamin C, hyperbaric oxygen chambers, intravenous ozone and chelation therapy, a technique to remove heavy metals from the body. The FDA has warned that chelation can cause serious and possibly fatal side-effects such as kidney failure.
Slepcevic also took her son to Ukraine for stem cell therapy following a protocol set by Jeff Bradstreet, a controversial anti-vaccine doctor. (Bradstreet died in an apparent suicide in 2015 shortly after his wellness center in Buford, Georgia, was raided by the FBI in an investigation into “frauds and swindles”.)
In April, Slepcevic, who is also a leader of the California chapter of Children’s Health Defense, the anti-vaccination group that Kennedy chaired until 2023, staged an Autism Health Summit in San Diego for the second year running.
The star speaker, beamed in on video, was Kennedy.
The health secretary described Slepcevic and her husband, Steve, as his “good friends”. He promised attenders that he planned to “create opportunities that extend across a lifetime”, and exhorted his audience to “work with us to drive solutions together”.
Slepcevic did not respond to a Guardian request for comment.
It was at the summit that Slepcevic announced a “pioneering” new experiment that she has initiated in partnership with a clinic in Tijuana, Mexico. Given its location, the center operates outside the FDA’s stringent controls, falling under the remit of the Mexican regulator Cofepris.
The Tijuana experiment, which is being billed as a “clinical trial” under Mexican oversight, will begin on 15 July. It will involve umbilical stem cells being given to a target group of 120 boys and girls aged seven to 15 who have an official autism diagnosis ranging from mild to severe.
The Guardian reports on the disturbing experiment on autistic children that features an unproven treatment given its blessing by RFK Jr.: stem cell infusion treatments, sold on the false premise that autism can be “cured.”
Billionaire, Peter Nygard, Offers Money To Black Women DNA, Stem Cells, Eggs & Embryos On TV!
investigation of fashion billionaire Peter Nygard's bizarre and depraved exploits. According to Hansen, Nygard is accused of taking stem cells from fetuses in order to extend his life. However, the septuagenarian is currently behind bars awaiting trial and is, described as withering away.
If you feel like blessing a mom of 4 who just went through a stem cell transplant and is eager to get home to her babies and get back on track with bills and return to a normal life…. My cashapp is $sammyyyyjo …anything helps !
Like these weekly* compilations? Tip me at $kaybarr1735 or check out my new(ly repurposed) Patreon! (*sorry this one’s a day late, I had a family emergency)
“[Community-created and -maintained] agroforests have reshaped the urban landscape and now attract an array of fauna, from birds to bees and even fireflies, drawn by the diversity of plant life thriving on improved soils. Perhaps most importantly, the agroforests offer free food and medicines to residents in need, plus shade and educational opportunities for the whole community[….]”
2. First giant pandas from China in decades make their public debut in San Diego
(image source) “Tensions between the U.S. and China had temporarily paused the program known as "panda diplomacy" in which China loans its native animals to zoos around the world […] as a show of goodwill[….] But the presence of [the two pandas in San Diego] appears to show a mending of the diplomatic relationship, which Chinese President Xi Jinping pledged to work toward in a meeting with President Biden last year. [… Gov. Newsom] called the giant pandas an example of how strong worldly partnerships can protect wildlife and their habitats[….]”
3. Good news for Europe's top economies as disposable income rises
“Poland experienced the largest increase in disposable income per capita, rising by 10.2% compared with a decrease of 2.7% in the last quarter of 2023. According to the OECD, this growth was "mainly driven by increases in employee compensation, social benefits other than in-kind transfers, and property income". […] In Germany, [household income per capita] rose by 1.4%, compared to just 0.1% in the previous quarter, partly driven by an increase in employee compensation.”
4. FDA approves nasal spray as first needle-free treatment for anaphylaxis
“The spray, which will be sold under the brand name Neffy, is seen as an alternative to EpiPen and other autoinjectors. […] “Some people, particularly children, may delay or avoid treatment due to fear of injections,” said Kelly Stone, an associate director at the FDA’s Center for Drug Evaluation and Research, adding that the availability of the nasal spray may reduce barriers to rapid treatment.”
5. [Colin Farrell] is launching a foundation to support adult[s] who have an intellectual disability
““We want to take a good look at residential potential for families with young adults who are ready to go out into the world and have a greater sense of community and connection,” says the actor. […] "It’s really important for James and for all of our kids to feel like they are wanted, to feel like they’re part of the community. Not just out of charitable endeavors or being nice and doing the right thing, but out of a sincere desire to engage and learn about each other."”
6. The Berlin Zoo is hoping for more German-born giant pandas as scans confirm a pregnancy
“Giant pandas have difficulty breeding and births are particularly welcomed. There are about 1,800 pandas living in the wild in China and a few hundred in captivity worldwide. […] The zoo noted that female pandas are only capable of reproducing for about 72 hours per year.”
7. Arizona school district highlights the benefits of free lunch
“A study by the University of Washington found free meals at school help reduce hunger, reduce the stigma tied to free lunch, and can help reduce childhood obesity. [… A cafeteria worker] said since the school district began offering free lunch, they have seen a positive shift in the cafeteria culture, and students seem happier. […] In September of 2023, the USDA […] loosened up its application threshold for applicants, allowing an estimated 3,000 more school districts in high-need areas to participate in the [CEP] program.”
8. Gigantic millipede lost to science for 126 years rediscovered in remote Madagascan jungle
“A further 20 species 'lost' to science were rediscovered during the expedition, including three iridescent species of fish and several species of ant-like flower beetles.”
9. The climate law’s $8.8B in home energy rebates are starting to roll out
“New York and Wisconsin are the first to launch their long-awaited Inflation Reduction Act programs meant to deploy everything from heat pumps to insulation. […] Once deployed, the DOE estimates, the home energy rebates will help save consumers up to $1 billion in annual energy costs and support an estimated 50,000 U.S. jobs in construction, manufacturing, and other sectors. They’ll also help clean up buildings, one of the biggest sources of carbon pollution in the country.”
10. Advance in stem cell therapy: New technique for manipulating stem cells opens door to novel treatments
“Recently, a team of McGill researchers discovered that by stretching, bending and flattening the nuclei of stem cells to differing degrees, they could generate precisely targeted cells that they could direct to become either bone or fat cells. […] The first applications of this discovery are likely to involve bone regeneration, possibly relating to dental or cranio-facial repair[….]”
August 1-7 news here | (all credit for images and written material can be found at the source linked; I don’t claim credit for anything but curating.)
Innovative Stem Cell Therapies: Transforming Regenerative Medicine and Patient Care
In recent years, stem cell therapy has emerged as a groundbreaking approach in regenerative medicine, offering patients innovative ways to support healing and recovery. A fundamental shift is occurring in healthcare—one that moves away from traditional, one-size-fits-all pharmaceutical solutions and toward personalized, biologically driven approaches. Physicians are now harnessing patients’ own stem cells to promote natural healing, offering a minimally invasive alternative to major surgical interventions.
At the forefront of this movement is Cell Surgical Network, a pioneering organization that emphasizes patient-driven regenerative medicine using a patient’s own cells. By leveraging autologous stem cell therapies, doctors are unlocking new possibilities for individuals seeking alternatives to conventional treatments.
The Power of Personal Stem Cell Therapy
Unlike traditional pharmaceutical interventions, which rely on mass-produced solutions, personal stem cell therapy utilizes a patient’s own cells to promote healing. This represents a paradigm shift in medicine, aligning with the body’s natural regenerative mechanisms.
The process of isolating a patient’s stem cells is relatively straightforward and minimally invasive. Stem cells are typically harvested from adipose (fat) tissue through a minor outpatient procedure. Once extracted, these cells can be reintroduced into areas of the body where healing support is needed. Because the cells originate from the patient’s own body, concerns over rejection or adverse immune reactions are significantly reduced.
This biological and patient-specific approach to medicine is gaining traction across multiple fields, including orthopedics, neurology, cardiology, and longevity-focused medicine.
Why Patients Are Choosing Stem Cell Therapy
The growing demand for minimally invasive medical solutions is driving the adoption of stem cell-based approaches. Patients are increasingly looking to avoid major surgical interventions and long recovery periods. Whether they are dealing with orthopedic challenges, neurological conditions, cardiovascular concerns, or are focused on longevity and performance, individuals are seeking options that align with how the body naturally repairs itself.
Traditional medicine often follows an “off-the-shelf” model, where patients receive standardized pharmaceutical treatments that may not address the root cause of their concerns. Stem cell therapy, by contrast, offers a highly personalized approach, working in harmony with the body’s own healing systems.
Key Areas Where Stem Cells Are Promoting Healing
Stem cell therapy is being integrated into multiple areas of medicine to support the body’s natural ability to repair and regenerate tissue. Some of the most exciting applications include:
Orthopedics and Sports Medicine
Patients experiencing joint discomfort, soft tissue injuries, or degenerative orthopedic conditions are turning to stem cell therapies as an alternative to surgery.
Athletes and active individuals are leveraging regenerative medicine to support recovery and performance without long downtimes.
Neurology
Researchers and clinicians are exploring how stem cells can be used to support neurological health and function.
There is growing interest in regenerative strategies that focus on neuroplasticity and the body’s ability to maintain and repair nerve tissues.
Cardiology
Personalized stem cell approaches are being studied for their potential to support cardiovascular health.
The idea of using the body’s own cells to promote healing represents a major departure from traditional pharmaceutical-based interventions.
Longevity and Performance-Based Medicine
The use of stem cells in age management and performance medicine is gaining attention as people seek to optimize their health and vitality.
Regenerative techniques are being explored for their role in enhancing cellular function, recovery, and overall well-being.
A Fundamental Shift in Medical Practice
This patient-centered approach to regenerative medicine represents a fundamental shift in how healthcare is delivered. Rather than focusing solely on symptom management, stem cell therapy emphasizes healing as the primary outcome. This shift aligns with the way the body has been designed to heal naturally, making regenerative medicine one of the most exciting frontiers in modern healthcare.
For physicians, integrating stem cell-based protocols into their practice offers a cutting-edge, biologically consistent approach that complements traditional medical techniques. Networks like Cell Surgical Network are helping clinicians stay at the forefront of this medical revolution, providing education, research, and patient access to minimally invasive regenerative solutions.
Conclusion
The move toward patient-specific regenerative medicine is transforming the pharmaceutical and medical industries. With an increasing emphasis on biological healing rather than symptom suppression, stem cell therapy is redefining the standard of care. Patients and physicians alike are recognizing the benefits of utilizing the body’s own regenerative capabilities, paving the way for a new era in medicine—one where healing takes precedence over intervention.
As demand for minimally invasive, patient-driven solutions continues to grow, stem cell therapy stands at the forefront of a revolution in personalized medicine—one that is reshaping how we think about health, recovery, and longevity.
